RAPT Therapeutics, Inc. (RAPT)

NASDAQ: RAPT · IEX Real-Time Price · USD

8.33

+0.21 (2.52%)

At close: May 3, 2024, 4:00 PM

8.30

-0.03 (-0.36%)

After-hours: May 3, 2024, 4:05 PM EDT

RAPT Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	290	855	592	1,085	485	603
Market Cap Growth	-	44.33%	-45.43%	123.77%	-19.54%	-
Enterprise Value	141	703	352	896	373	525
PE Ratio	-7.32	-7.32	-7.06	-15.68	-9.17	-14.02
PS Ratio	-	-	387.84	284.61	96.19	-
PB Ratio	1.99	5.81	2.42	5.82	4.66	8.24
P/FCF Ratio	-8.71	-8.71	-8.27	-17.57	-11.86	-16.60
P/OCF Ratio	-8.81	-8.81	-8.37	-17.78	-11.98	-16.99
EV/Sales Ratio	-	-	230.62	234.87	74.07	-
EV/EBITDA Ratio	-6.21	-6.21	-4.35	-13.13	-7.35	-12.81
EV/EBIT Ratio	-6.02	-6.02	-4.20	-12.94	-7.20	-12.41
EV/FCF Ratio	-7.16	-7.16	-4.92	-14.50	-9.13	-14.47
Debt / Equity Ratio	0.05	0.05	0.04	-	-	-
Debt / EBITDA Ratio	-0.06	-0.06	-0.11	-	-	-
Debt / FCF Ratio	-0.07	-0.07	-0.13	-	-	-
Quick Ratio	7.28	7.28	17.51	19.77	9.50	8.36
Current Ratio	7.41	7.41	17.77	20.11	9.85	8.70
Asset Turnover	0	0	0.01	0.02	0.04	0
Return on Equity (ROE)	-63.10%	-63.10%	-41.70%	-39.70%	-45.10%	358.40%
Return on Assets (ROA)	-55.50%	-55.50%	-37.90%	-36.80%	-39.30%	-55.80%
Return on Capital (ROIC)	-82.54%	-82.54%	-33.76%	-37.13%	-51.08%	-59.67%
Earnings Yield	-39.91%	-13.66%	-14.16%	-6.38%	-10.91%	-7.13%
FCF Yield	-33.55%	-11.49%	-12.09%	-5.69%	-8.43%	-6.03%
Buyback Yield / Dilution	-17.82%	-17.82%	-18.80%	-13.49%	-455.27%	-598.45%
Total Shareholder Return	-17.82%	-17.82%	-18.80%	-13.49%	-455.27%	-598.45%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).